Skip to main content

Table 1 Serum and biochemical indicators of Ang II rats treated with vehicle or DAPA for 4 weeks

From: Dapagliflozin: a sodium–glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling

 

CTL

CTL + DAPA

Ang II

Ang II + DAPA

Glu (mM)

8.29 ± 1.29

8.33 ± 1.28

8.09 ± 1.12

8.05 ± 1.17

INS (pg/ml)

223 ± 38.94

224.53 ± 66.16

205.95 ± 49.33

215.59 ± 43.51

TC (mM)

1.8 ± 0.2

1.6 ± 0.37

1.98 ± 0.48

1.85 ± 0.27

TG (mM)

1.14 ± 0.49

1.08 ± 0.46

1.31 ± 0.46

1.22 ± 0.56

LDL-C (mM)

0.35 ± 0.1

0.36 ± 0.09

0.35 ± 0.12

0.38 ± 0.07

HDL-C (mM)

0.53 ± 0.16

0.57 ± 0.05

0.51 ± 0.19

0.59 ± 0.1

ALT (U/I)

53.67 ± 8.59

61 ± 14.3

59.5 ± 7.61

52.33 ± 6.62

AST (U/I)

244.09 ± 10.05

246.16 ± 38.39

229.17 ± 17.41

236 ± 12.18

CK (U/I)

331.14 ± 11.81

327.08 ± 15.24

317.88 ± 18.12

321.81 ± 15.85

CK-MB (U/I)

338.28 ± 13.79

337.41 ± 15.76

318.38 ± 20.62

326.69 ± 16.81

LDH (U/I)

360.22 ± 13.26

359.74 ± 13.15

340.61 ± 24.75

354.96 ± 14.97

BUN (mM)

6.61 ± 1.43

6.88 ± 1.76

7.84 ± 2.13

8.64 ± 2.05

SCr (μmol/l)

18.12 ± 3.32

19.72 ± 2.89

20.05 ± 4.59

18.48 ± 2.59

UA (μmol/l)

11.3 ± 7.12

13.38 ± 5.86

8.22 ± 3.5

7.57 ± 3.95

  1. Values are presented as mean ± SD (n = 6 rats per group)
  2. Every parameter showed no significant difference among the four groups. Data are not significant for each group
  3. Glu glucose, INS insulin, TC total serum cholesterol, TG triglyceride, LDL low-density lipoprotein, HDL high-density lipoprotein, SCr serum creatinine, ALT serum alanine aminotransferase, AST aspartate aminotransferase, LDH lactate dehydrogenase, CK creatine kinase